203 related articles for article (PubMed ID: 11839563)
1. Translocation, deletion/amplification, and expression of HMGIC and MDM2 in a carcinoma ex pleomorphic adenoma.
Röijer E; Nordkvist A; Ström AK; Ryd W; Behrendt M; Bullerdiek J; Mark J; Stenman G
Am J Pathol; 2002 Feb; 160(2):433-40. PubMed ID: 11839563
[TBL] [Abstract][Full Text] [Related]
2. Recurrent rearrangements of the PLAG1 and HMGA2 genes in lacrimal gland pleomorphic adenoma and carcinoma ex pleomorphic adenoma.
Andreasen S; von Holstein SL; Homøe P; Heegaard S
Acta Ophthalmol; 2018 Nov; 96(7):e768-e771. PubMed ID: 29437290
[TBL] [Abstract][Full Text] [Related]
3. Lacrimal gland pleomorphic adenoma and carcinoma ex pleomorphic adenoma: genomic profiles, gene fusions, and clinical characteristics.
von Holstein SL; Fehr A; Persson M; Nickelsen M; Therkildsen MH; Prause JU; Heegaard S; Stenman G
Ophthalmology; 2014 May; 121(5):1125-33. PubMed ID: 24468654
[TBL] [Abstract][Full Text] [Related]
4. High-resolution genomic profiling of adenomas and carcinomas of the salivary glands reveals amplification, rearrangement, and fusion of HMGA2.
Persson F; Andrén Y; Winnes M; Wedell B; Nordkvist A; Gudnadottir G; Dahlenfors R; Sjögren H; Mark J; Stenman G
Genes Chromosomes Cancer; 2009 Jan; 48(1):69-82. PubMed ID: 18828159
[TBL] [Abstract][Full Text] [Related]
5. Expression of reciprocal hybrid transcripts of HMGIC and FHIT in a pleomorphic adenoma of the parotid gland.
Geurts JM; Schoenmakers EF; Röijer E; Stenman G; Van de Ven WJ
Cancer Res; 1997 Jan; 57(1):13-7. PubMed ID: 8988031
[TBL] [Abstract][Full Text] [Related]
6. Chromosomal translocation t(8;12) induces aberrant HMGIC expression in aggressive angiomyxoma of the vulva.
Nucci MR; Weremowicz S; Neskey DM; Sornberger K; Tallini G; Morton CC; Quade BJ
Genes Chromosomes Cancer; 2001 Oct; 32(2):172-6. PubMed ID: 11550285
[TBL] [Abstract][Full Text] [Related]
7. Expression of PLAG1 and HMGIC proteins and fusion transcripts in radiation-associated pleomorphic adenomas.
Enlund F; Nordkvist A; Sahlin P; Mark J; Stenman G
Int J Oncol; 2002 Apr; 20(4):713-6. PubMed ID: 11894114
[TBL] [Abstract][Full Text] [Related]
8. Concurrent cytogenetic, interphase fluorescence in situ hybridization and DNA flow cytometric analyses of a carcinoma ex-pleomorphic adenoma of parotid gland.
el-Naggar AK; Lovell M; Callender DL; Ordonez NG; Killary AM
Cancer Genet Cytogenet; 1998 Dec; 107(2):132-6. PubMed ID: 9844608
[TBL] [Abstract][Full Text] [Related]
9. Identification of NFIB as recurrent translocation partner gene of HMGIC in pleomorphic adenomas.
Geurts JM; Schoenmakers EF; Röijer E; Aström AK; Stenman G; van de Ven WJ
Oncogene; 1998 Feb; 16(7):865-72. PubMed ID: 9484777
[TBL] [Abstract][Full Text] [Related]
10. Consistent PLAG1 and HMGA2 abnormalities distinguish carcinoma ex-pleomorphic adenoma from its de novo counterparts.
Katabi N; Ghossein R; Ho A; Dogan S; Zhang L; Sung YS; Antonescu CR
Hum Pathol; 2015 Jan; 46(1):26-33. PubMed ID: 25439740
[TBL] [Abstract][Full Text] [Related]
11. Genetic analysis of the human oncoprotein MDM2 in benign and malignant tumors of the salivary gland.
Schlott T; Nagel H; Laskawi R; Eiffert H; Droese M
Pathobiology; 2001; 69(2):67-76. PubMed ID: 11752900
[TBL] [Abstract][Full Text] [Related]
12. t(3;8) as the sole chromosomal abnormality in a myoepithelial carcinoma ex pleomorphic adenoma: a putative progression event.
Bell D; N Myers J; Rao PH; El-Naggar AK
Head Neck; 2013 Jun; 35(6):E181-3. PubMed ID: 22287457
[TBL] [Abstract][Full Text] [Related]
13. HMGA2 is a specific immunohistochemical marker for pleomorphic adenoma and carcinoma ex-pleomorphic adenoma.
Mito JK; Jo VY; Chiosea SI; Dal Cin P; Krane JF
Histopathology; 2017 Oct; 71(4):511-521. PubMed ID: 28463429
[TBL] [Abstract][Full Text] [Related]
14. The role of the p53 gene in the malignant transformation of pleomorphic adenomas of the parotid gland.
Righi PD; Li YQ; Deutsch M; McDonald JS; Wilson KM; Bejarano P; Stambrook PJ; Osterhage D; Nguyen C; Gluckman JL
Anticancer Res; 1994; 14(5B):2253-7. PubMed ID: 7840532
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical study of c-erbB-2 oncoprotein overexpression in human major salivary gland carcinoma: an indicator of aggressiveness.
Sugano S; Mukai K; Tsuda H; Hirohashi S; Furuya S; Shimosato Y; Ebihara S; Takeyama I
Laryngoscope; 1992 Aug; 102(8):923-7. PubMed ID: 1353853
[TBL] [Abstract][Full Text] [Related]
16. Non-invasive (intracapsular) carcinoma ex pleomorphic adenoma: recognition of focal carcinoma by HER-2/neu and MIB1 immunohistochemistry.
Di Palma S; Skálová A; Vanìèek T; Simpson RH; Stárek I; Leivo I
Histopathology; 2005 Feb; 46(2):144-52. PubMed ID: 15693886
[TBL] [Abstract][Full Text] [Related]
17. Subsets of salivary duct carcinoma defined by morphologic evidence of pleomorphic adenoma, PLAG1 or HMGA2 rearrangements, and common genetic alterations.
Chiosea SI; Thompson LD; Weinreb I; Bauman JE; Mahaffey AM; Miller C; Ferris RL; Gooding WE
Cancer; 2016 Oct; 122(20):3136-3144. PubMed ID: 27379604
[TBL] [Abstract][Full Text] [Related]
18. PLAG1 alteration in carcinoma ex pleomorphic adenoma: immunohistochemical and fluorescence in situ hybridization studies of 22 cases.
Bahrami A; Dalton JD; Shivakumar B; Krane JF
Head Neck Pathol; 2012 Sep; 6(3):328-35. PubMed ID: 22485045
[TBL] [Abstract][Full Text] [Related]
19. An analysis of PLAG1 and HMGA2 rearrangements in salivary duct carcinoma and examination of the role of precursor lesions.
Bahrami A; Perez-Ordonez B; Dalton JD; Weinreb I
Histopathology; 2013 Aug; 63(2):250-62. PubMed ID: 23738717
[TBL] [Abstract][Full Text] [Related]
20. MDM2 amplification in a primary alveolar rhabdomyosarcoma displaying a t(2;13)(q35;q14).
Meddeb M; Valent A; Danglot G; Nguyen VC; Duverger A; Fouquet F; Terrier-Lacombe MJ; Oberlin O; Bernheim A
Cytogenet Cell Genet; 1996; 73(4):325-30. PubMed ID: 8751388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
